SKLB-197, exhibits good pharmacokinetic properties, could be a promising lead compound for drug discovery targeting ATR. The pharmacokinetic (PK) studies were performed by Medicilon.

Immune checkpoint inhibition therapies have been used for multiple cancer research. H11-HLE is a tool molecule that allows the interrogation of the contribution of Fc in mediating immune checkpoint therapy. Half-life extended H11 (H11-HLE) induces potent anti-tumor efficacy in mouse syngeneic tumor models.

Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent forms of chronic liver diseases. Estrogen-related receptor alpha (ERRα) is a viable target for NAFLD.

Psoriasis is a common immune-mediated skin disorder manifesting in abnormal skin plaques, and PDE4 is an effective target for the treatment of inflammatory diseases such as psoriasis.

The p21 activated kinase 4 (PAK4) is serine/threonine protein kinase that is critical for cancer progression. 6-Ethynyl-1H-indole derivative 55 is a potent and selective PAK4 inhibitor (Ki=10.2 nM). Compound 55 is effective in the treatment of metastatic cancer. The pharmacokinetic study of Compound 55 was carried out by Medicilon.

德甲联赛官网为德睿智药自主研发的GLP-1RA小分子口服药物MDR-001提供了原料药工艺开发和制剂研发服务，助力其研发提速。

祝贺拓领博泰TollB-001片获FDA临床试验批准！这是拓领博泰团队近二十年的免疫调控机理研究和免疫调控药物研究的厚积薄发，也是德甲联赛官网药学研究CDMO服务平台的又一次成功经验积淀。

德甲联赛官网将持续拓展眼科药物领域的创新技术，助力更多眼科药物跑出研发“加速度”！

德甲联赛官网助力GT919完成了其从药物发现到临床申报，包括药物发现、药学研究、临床前研究等一站式临床前研究服务

德甲联赛官网祝贺轩竹生物完全敲除岩藻糖的双抗ADC药物KM501获批临床！德甲联赛官网符合GLP规范的临床前研究服务再添成功案例！